| |||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Background Strain C57BL/6J Donor Strain 129P2 via E14TG2a ES cell line Generation N5F2p Donating Investigator The Jackson Laboratory, Appearance
black
Related Genotype: a/aDescription
Mice homozygous for the Tgfatm1Ard mutation develop normally, are of normal size, weight, and health, and are fertile. They display a pronounced waviness in the coat and whiskers, and dramatic derangement of the hair follicles. Older homozygous mice occasionally show some corneal inflammation that may be the result of a defect in wound healing.Development
The Tgfatm1Ard mutant strain was developed in the laboratory of Dr. Ashley Dunn at the Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch. The 129-derived E14 ES cell line was used. The C57BL/6J strain was generated by backcrossing mice carrying the Tgfatm1Ard mutation 5 or more times to C57BL/6J mice.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Tgfa
000004 ABP/LeJ 002863 B6.Cg-Tgfawa1/J View Strains carrying other alleles of Tgfa (2 strains)
Congenic Nomenclature
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Tgfatm1Ard/Tgfatm1Ard
involves: 129P2/OlaHsd * C57BL/6
- skin/coat/nails phenotype
- abnormal hair follicle orientation (MGI Ref ID J:4606)
- increased curvature of hairs (MGI Ref ID J:4606)
- waved hair (MGI Ref ID J:4606)
- attenuated slightly with age
- touch/vibrissae phenotype
- curly vibrissae (MGI Ref ID J:4606)
- attenuated slightly with age
- vision/eye phenotype
- eyelids open at birth (MGI Ref ID J:4606)
- increased incidence of corneal inflammation (MGI Ref ID J:4606)
- immune system phenotype
- increased incidence of corneal inflammation (MGI Ref ID J:4606)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Tgfatm1Ard relatedInternal/Organ Research
Wound Healing (delayed/impaired)
Cancer Research
Growth Factors/Receptors/Cytokines
Dermatology Research
Skin and Hair Texture Defects
Endocrine Deficiency Research
Skin Defects
Immunology and Inflammation Research
Growth Factors/Receptors/Cytokines
| Allele Symbol | Tgfatm1Ard | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Ashley R Dunn | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | Tgfalpha -; | ||
| Mutation Made By | Ashley Dunn, Ludwig Institute for Cancer Research | ||
| Strain of Origin | 129P2/OlaHsd | ||
| ES Cell Line Name | E14 | ||
| ES Cell Line Strain | 129P2/OlaHsd | ||
| Gene Symbol and Name | Tgfa, transforming growth factor alpha | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | RATTGFAA; TFGA; TGFAA; wa-1; wa1; waved 1; | ||
| General Note | In conjunction with Fgf7tm1Efu, double homozygous mutant mice display no additional abnormalities nor increase in severity of phenotypes over individual homozygous mutants. (J:31155) | ||
| Molecular Note | A neomycin cassette was inserted into exon 3 of the gene. [MGI Ref ID J:4606] | ||
Genotyping Protocols
NEOTD (Generic Neo), STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Mann GB; Fowler KJ; Gabriel A; Nice EC; Williams RL; Dunn AR. 1993. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73(2):249-61. [PubMed: 8477444] [MGI Ref ID J:4606]
Abbott BD; Buckalew AR; DeVito MJ; Ross D; Bryant PL; Schmid JE. 2003. EGF and TGF-alpha expression influence the developmental toxicity of TCDD: dose response and AhR phenotype in EGF, TGF-alpha, and EGF + TGF-alpha knockout mice. Toxicol Sci 71(1):84-95. [PubMed: 12520078] [MGI Ref ID J:87957]
Bryant PL; Schmid JE; Fenton SE; Buckalew AR; Abbott BD. 2001. Teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the expression of EGF and/or TGF-alpha. Toxicol Sci 62(1):103-14. [PubMed: 11399798] [MGI Ref ID J:87956]
Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ Jr; Yuspa SH. 1995. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res 55(9):1883-93. [PubMed: 7728756] [MGI Ref ID J:24930]
Tgfatm1Ard relatedAbbott BD; Best DS; Narotsky MG. 2005. Teratogenic effects of retinoic acid are modulated in mice lacking expression of epidermal growth factor and transforming growth factor-alpha. Birth Defects Res A Clin Mol Teratol 73(4):204-17. [PubMed: 15799028] [MGI Ref ID J:101656]
Abbott BD; Buckalew AR; DeVito MJ; Ross D; Bryant PL; Schmid JE. 2003. EGF and TGF-alpha expression influence the developmental toxicity of TCDD: dose response and AhR phenotype in EGF, TGF-alpha, and EGF + TGF-alpha knockout mice. Toxicol Sci 71(1):84-95. [PubMed: 12520078] [MGI Ref ID J:87957]
Blum M. 1998. A null mutation in TGF-alpha leads to a reduction in midbrain dopaminergic neurons in the substantia nigra. Nat Neurosci 1(5):374-7. [PubMed: 10196526] [MGI Ref ID J:49629]
Bryant PL; Schmid JE; Fenton SE; Buckalew AR; Abbott BD. 2001. Teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the expression of EGF and/or TGF-alpha. Toxicol Sci 62(1):103-14. [PubMed: 11399798] [MGI Ref ID J:87956]
Charalambous CT; Hannigan A; Tsimbouri P; McPhee GM; Wilson JB. 2007. Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF{alpha} prior to neoplasia. Carcinogenesis 28(8):1839-48. [PubMed: 17361012] [MGI Ref ID J:124325]
Egger B; Procaccino F; Lakshmanan J; Reinshagen M; Hoffmann P ; Patel A ; Reuben W ; Gnanakkan S ; Liu L ; Barajas L ; Eysselein VE. 1997. Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology 113(3):825-32. [PubMed: 9287974] [MGI Ref ID J:43892]
Getchell TV; Narla RK; Little S; Hyde JF; Getchell ML. 2000. Horizontal basal cell proliferation in the olfactory epithelium of transforming growth factor-alpha transgenic mice Cell Tissue Res 299(2):185-92. [PubMed: 10741459] [MGI Ref ID J:61226]
Guo L; Degenstein L; Fuchs E. 1996. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev 10(2):165-75. [PubMed: 8566750] [MGI Ref ID J:31155]
Kim I; Mogford JE; Chao JD; Mustoe TA. 2001. Wound epithelialization deficits in the transforming growth factor-alpha knockout mouse. Wound Repair Regen 9(5):386-90. [PubMed: 11896982] [MGI Ref ID J:103517]
Madtes DK; Elston AL; Hackman RC; Dunn AR; Clark JG. 1999. Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice. Am J Respir Cell Mol Biol 20(5):924-34. [PubMed: 10226062] [MGI Ref ID J:114268]
Minami S; Iwamoto R; Mekada E. 2008. HB-EGF decelerates cell proliferation synergistically with TGFalpha in perinatal distal lung development. Dev Dyn 237(1):247-58. [PubMed: 18069687] [MGI Ref ID J:130339]
Sun H; Oakley B. 2002. Development of anterior gustatory epithelia in the palate and tongue requires epidermal growth factor receptor. Dev Biol 242(1):31-43. [PubMed: 11795938] [MGI Ref ID J:74312]
Xian CJ; Li L; Deng YS; Zhao SP; Zhou XF. 2001. Lack of effects of transforming growth factor-alpha gene knockout on peripheral nerve regeneration may result from compensatory mechanisms. Exp Neurol 172(1):182-8. [PubMed: 11681850] [MGI Ref ID J:119305]
Xian CJ; Mardell CE; Read LC. 1999. Specificity of the localization of transforming growth factor-alpha immunoreactivity in colon mucosa. J Histochem Cytochem 47(7):949-58. [PubMed: 10375383] [MGI Ref ID J:56069]
Colony Maintenance
Breeding & Husbandry The Tgfatm1Ard strain is maintained by mating homozygous siblings. Homozygous mice may be ordered. Corneas of homozygous mutants are often scarred from injuries that do not heal normally. Expected coat color from breeding:Black Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.